BCL2L1 and type 2 diabetes mellitus: Combined treatment with metformin and PA was effective in the inhibition of pro-apoptotic factor Bax and in the activation of anti-apoptotic factor Bcl-xl that may mediate their neuroprotective effect on the background of T2DM.